Nitroimidazopyrazinones with Oral Activity against Tuberculosis and Chagas Disease in Mouse Models of Infection. (2022)
Attributed to:
Understanding the molecular basis and role of parasite dormancy in Chagas disease
funded by
MRC
Abstract
No abstract provided
Bibliographic Information
Digital Object Identifier: http://dx.doi.org/10.1021/acs.jmedchem.2c00972
PubMed Identifier: 36111399
Publication URI: http://europepmc.org/abstract/MED/36111399
Type: Journal Article/Review
Volume: 65
Parent Publication: Journal of medicinal chemistry
Issue: 19
ISSN: 0022-2623